Pfizer enters Cambodia

PfizerUS-based pharma company Pfizer is about to enter the Cambodian market  in a partnership with Switzerland’s DKSH Group, a company focused on distribution and marketing of pharmaceutical products in Asia.

DKSH Business Unit Healthcare has said it has signed an agreement to provide marketing and sales, logistics, distribution, credit management and collection services in Cambodia for Pfizer.

DKSH says the new partnership will “further strengthen its market position in Southeast Asia while contributing incrementally to the group’s overall earnings and profitability over time.”

Earlier, DKSH Healthcare was appointed by Pfizer’s Thailand subsidiary as the sole nationwide distributor for all of its pharmaceutical products in Cambodia, effective at the beginning of 2013.

“We believe our partnership with DKSH will translate into wider and easier access to our high-quality medicines in Cambodia so that more people will benefit from our healthcare innovations,” said Pichitchai Jak-paisan, finance director and Indochina general manager for Pfizer (Thailand).

He said Pfizer chose DKSH as it has a “well-established nationwide infrastructure in Cambodia, well-trained local staff and an in-depth understanding of the Cambodian market.”

The firm’s expertise in marketing and sales as well as its dedication to compliance and quality will also mean better services to Pfizer’s valued customers and business partners, he added.

 



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

US-based pharma company Pfizer is about to enter the Cambodian market  in a partnership with Switzerland's DKSH Group, a company focused on distribution and marketing of pharmaceutical products in Asia. DKSH Business Unit Healthcare has said it has signed an agreement to provide marketing and sales, logistics, distribution, credit management and collection services in Cambodia for Pfizer. DKSH says the new partnership will "further strengthen its market position in Southeast Asia while contributing incrementally to the group's overall earnings and profitability over time." Earlier, DKSH Healthcare was appointed by Pfizer's Thailand subsidiary as the sole nationwide distributor for all of...

PfizerUS-based pharma company Pfizer is about to enter the Cambodian market  in a partnership with Switzerland’s DKSH Group, a company focused on distribution and marketing of pharmaceutical products in Asia.

DKSH Business Unit Healthcare has said it has signed an agreement to provide marketing and sales, logistics, distribution, credit management and collection services in Cambodia for Pfizer.

DKSH says the new partnership will “further strengthen its market position in Southeast Asia while contributing incrementally to the group’s overall earnings and profitability over time.”

Earlier, DKSH Healthcare was appointed by Pfizer’s Thailand subsidiary as the sole nationwide distributor for all of its pharmaceutical products in Cambodia, effective at the beginning of 2013.

“We believe our partnership with DKSH will translate into wider and easier access to our high-quality medicines in Cambodia so that more people will benefit from our healthcare innovations,” said Pichitchai Jak-paisan, finance director and Indochina general manager for Pfizer (Thailand).

He said Pfizer chose DKSH as it has a “well-established nationwide infrastructure in Cambodia, well-trained local staff and an in-depth understanding of the Cambodian market.”

The firm’s expertise in marketing and sales as well as its dedication to compliance and quality will also mean better services to Pfizer’s valued customers and business partners, he added.

 



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

NO COMMENTS

Leave a Reply